Tian, D., Chen, W., Xu, Q., Li, X., & Lv, Q
Treatment with cagrilintide/semaglutide 2.4 mg/2.4 mg led to clinically relevant reductions in blood pressure across a wide range of participant subgroups and resulted in a greater proportion of participants able to decrease or stop treatment with antihypertensive medications compared with placebo and other monotherapies
GLP-1 drugs do not carry seizure risk or cause stimulant-like side effects
Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa
Novo Nordisk said the ruling strengthens confidence for foreign pharmaceutical companies operating in China and reflects official support for protecting medical innovation
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) occurs when blood flow to the optic nerve head is compromised, causing sudden, irreversible vision loss, typically impacting only one eye at a time